Munir Abdul Aziz
Biography
Munir Abdul Aziz is a partner in the Corporate and M&A Practice Group of Wong & Partners and has been in practice since 1998, focusing on mergers and acquisitions, corporate reorganisations, equity capital markets transactions, venture capital and private equity, joint ventures, and general commercial transactions.
Munir is listed in the Hall of Fame by Legal 500 Asia Pacific for Corporate and M&A since 2025, and is also noted as a Leading Partner for Capital Markets since 2022. He is also ranked Band 1 by Chambers Asia Pacific for Corporate/M&A (since 2026). Additionally, Munir was named Managing Partner of the Year in 2021 and Dealmaker of the Year in 2017 and 2020 at the Asian Legal Business Malaysia Law Awards.
Munir has also worked in the London and Melbourne offices of Baker & McKenzie International.
Practice Focus
Munir has represented a number of multinational corporations in connection with takeovers, acquisitions, divestments of shares and assets, and joint ventures. He has also worked on corporate reorganisations and de-mergers involving leading publicly listed Malaysian companies. Munir has also been involved in domestic and international securities transactions including bond offerings and initial public offerings.
Representative Legal Matters
- Assisted the consortium of the joint offerors, Gateway Development Alliance Sdn. Bhd., formed with Pantai Panaroma Sdn. Bhd. (a wholly owned subsidiary of UEM Holdings Berhad which in turn is a wholly owned subsidiary of Khazanah Nasional Berhad), Kwasa Aktif Sdn. Bhd. (a wholly-owned subsidiary of Employees Provident Fund), and GIP Aurea Pte Ltd (an entity within the Global Infrastructure Partners group) in its successful privatization of Malaysia Airports Holdings Berhad (MAHB) through a conditional voluntary general offer for all the shares of MAHB not already held by the consortium. MAHB is the publicly listed operator of 39 airports in Malaysia including the Kuala Lumpur International Airport, and is also the operator of the Sabiha Gokcen International Airport in Turkiye. This significant and transformative takeover in the Malaysian aviation sector is based on a total equity value of RM 18.4 billion (estimated USD 4.17 billion) and is named the Best Privatisation Deal of 2025 by The Edge Malaysia.
- Represented Permodalan Nasional Berhad (PNB) as a Lead Counsel in connection with the sale of PNB and AmanahRaya Trustees Berhad’s (as trustee for the unit trust funds which hold shares in UMW Holdings Berhad (UMW)) equity interest of approximately 61.18% in UMW to Sime Darby Enterprise Sdn Bhd (SDESB) (as purchaser) and Sime Darby Holdings Berhad (as warrantor) for a total cash consideration of MYR 3.574 billion or MYR 5 per share. This deal was named Best M&A Deal in 2024 by The Edge Malaysia.
- Acted as lead counsel to Quadria Capital and its co-investors in the privatisation of Apex Healthcare Berhad, via Pharmora Investment Holdings Pte. Ltd.. Valued at approximately MYR 1.9 billion, this transaction is notable as the largest healthcare take-private transaction ever in Malaysia, alongside being the largest healthcare take-private and pharmaceutical transaction in Southeast Asia over the past five years.
- Advised IHH Healthcare Berhad (IHH) on (i) the disposal of the entire issued ordinary share capital of IMU Health Sdn Bhd by IHH to Inbound Education Holdings Sdn Bhd, a consortium between TPG, Hong Leong and EPF; (ii) the restructuring of IMU Education Sdn Bhd to transfer of a hospital to IMU Omega Sdn Bhd (IMU Omega); and (iii) the disposal of the entire issued share capital of IMU Omega to Columbia Asia Sdn Bhd.
- Advised PETRONAS Chemicals Group Berhad (PCG) on its EUR 2.3 billion acquisition of Perstorp Holding AB. We provided PCG with support for the transaction across all key areas including due diligence in multiple jurisdictions, transaction documentation and negotiation, and holistic legal and regulatory advice. A total of 155 lawyers in 25 Baker McKenzie offices across four continents had worked on the matter.
- Advised Pathology Asia Holdings Pte. Ltd., one of the largest independent clinical diagnostic service providers in Southeast Asia and a portfolio company of leading global private equity group TPG, in connection with the acquisition of a molecular screening and diagnostics services provider in Malaysia.
- Acted for Bank of America Singapore Limited on the MYR 2.15 billion placement of ANZ Funds Pty Ltd (ANZ)’s shares in AMMB Holdings Berhad (AMMB) by an affiliate of BofA and CIMB Investment Bank Berhad to (a) investors outside of the United States in accordance with Regulation S under the US Securities Act of 1993 and (b) Malaysian investors in compliance with the Capital Markets and Services Act 2007. On the closing of the placement, ANZ’s shareholding in AMMB reduced from 21.7% to 5.2% and is in line with ANZ’s strategy of simplifying the bank’s operations.
- Acted for Telekom Malaysia Berhad (TM) in connection with its internal reorganisation which involved the transfer of the telecommunication businesses of TM and its selected wholly owned subsidiaries to TM Technology Services Sdn Bhd. This internal reorganisation was significant for our client as it marks the next phase of transformation for TM group to be the enabler of a digital Malaysia, to further improve the operational efficiencies of the group, to streamline processes and to simplify customer touchpoints to provide a more seamless customer experience.
- Advised the Joint Offerors, comprised of Tianshui Huatian Technology Co., Ltd (TSHT), a public listed company in the People's Republic of China, together with Tianshui Huatian Electronics Group Co., Ltd, and the existing shareholders of Unisem (M) Berhad (Unisem), in connection with their pre-conditional voluntary conditional take-over of 428,553,254 shares of Unisem, which represents 58.94% of the issued share capital of Unisem not already owned by the Joint Offerors, for a total consideration of MYR 1.407 billion.
- Advised Shell Overseas Holdings Limited (Shell) on its USD 66.3 million (MYR 275 million) sale of its 51% interest in Shell Refining Company (Federation of Malaya) Berhad (SRC) to Malaysia Hengyuan International Limited, a Labuan incorporated subsidiary of Shandong Hengyuan Petrochemical Company Limited (Shandong Hengyuan). The sale marks the first overseas refinery acquisition by Shandong Hengyuan and the completion triggered a mandatory takeover offer for the remaining shares of SRC held by shareholders other than Shell.
Professional Associations and Memberships
-
Honorary Secretary of the Malaysian Mergers & Acquisitions Association
Admissions
- Singapore (2002)
- Malaysia (1998)
- England & Wales~United Kingdom (1997)
Education
- Oxford University (M.A., Hons) (2005)
- Cambridge University (LL.M.) (1997)
- Oxford University (B.A. Jurisprudence, Honors) (1996)
Languages
- English
- Malay
Previous Offices
- London
- Melbourne
Wong & Partners is a member of Baker & McKenzie International.